A solid overview of psychotropic drugs ‘Fundamentals of clinical psychopharmacology 4th edition’, edited by Ian M. Anderson and R. Hamish McAllister-Williams.…
Joel Elkes (1913–2015) A pioneer of neuropsychopharmacology, Joel Elkes’ research on the drug chlorpromazine helped revolutionise the treatment of those with psychotic illness.…
Blood test could show whether an antidepressant is effective, research suggests Psychiatrists could be on the way to developing a test that predicts which patients with depression will benefit from which antidepressant.…
A useful reference text of psychotropic medicines ‘Clinical handbook of psychotropic drugs 21st edition’, edited by Ric M Procyshyn, Kalyna Z Bezchlibnyk-Butler, J Joel Jeffries.…
Sleep disorders: treatment Selecting the most appropriate drug treatments for sleep disorders in the absence of trial data or evidence-based protocols.…
‘Digital pill’ assessed for approval by FDA A drug embedded with a digital sensor that records when a patient’s stomach is ingesting the medicine is being assessed for approval by the US medicines safety watchdog.…
Widespread prescribing of antipsychotics for intellectually disabled people revealed As many as 71% of adults with a learning disability were prescribed an antipsychotic when they had no record of any mental illness, a study reported in The BMJ has found.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
‘Urgent reform’ to pharmaceutical care for people with learning disabilities needed, says RPS Current system of care failing to deliver basic standards for patients, Society warns.…
Medical benefits of cannabis can be separated from unwanted side effects Scientists have found that inhibiting the effects of a certain receptor in the brains of mice can prevent negative effects of cannabis but keeps benefits such as pain relief.…
